Audra M. Craig-Walker

Fournitures Hospitalières SAS operates as a holding company with interests in the distribution of orthopedic, cardiovascular, and surgical equipment and supplies. The company was founded by André Hermann in 1964 and is headquartered in Heimsbrunn, France.

Protéus SA discovers, engineers, and manufactures proteins for industrial applications. It operates as a biotechnology company that focuses on the discovery, engineering and manufacturing of proteins of industrial interest, and on the development of protein-based bioprocesses. The company was founded on August 11, 1998 and is headquartered in Paris, France.

Domain Therapeutics SA discovers and develops drug candidates targeting G-protein coupled receptors (GPCR) in all major therapeutic fields. The firm?s products include technologies, such as DTect-All and BioSens-All. Its services encompass allosteric modulators identification, biased ligands selection, orphan and historically intractable GPCRs address and high throughput screening campaign. The company was founded by Maurice Isra?l, Pierre Potier, Bernard Jacques Alex Gilly, Yves Dunant and Pascal Neuville in 2008 and is headquartered in Illkirch-Graffenstaden, France.

PALUMED SA develops and produces pharmaceutical products for the treatment of Alzheimer's disease. The firm specializes in the development and production of new antimalarial agents and antibacterial molecules. The company was founded on December 8, 2000 and is headquartered in Castanet-Tolosan, France.

BPIFrance Investissement SAS (BPIfrance Investissement) is the private equity arm and subsidiary of State-owned Banque Publique d'Investissement in France. Formerly known as CDC Entreprises SAS, the firm was established in 1994 to carry out public-interest missions such as employment creation and momentum initiation in the private equity field. In 2013 they became BPIfrance Investissement when CDC Entreprises, FSI and FSI Régions merged. Headquartered in Paris, BPIfrance Investissement invests of behalf of the Government of France, as well as for third parties including FEI-Fonds Européen d'Investissement, BEI-Banque Européenne d'Investissement and BPCE SA. The firm invests directly or indirectly in SMEs and intermediate-sized companies at all stages of their development.

InGen Biosciences SA is engaged in the development of in-vitro diagnostic products for use in medical biology laboratories. The company was founded in 1993 and it is headquartered in Chilly-Mazarin, France.

UroMems SASdesigns and develops implantable medical devices. Its product is an active implantable medical device which compensates for sphincter insufficiency with the help of a MyoElectroMechanical System. The company was founded by Hamid Lamraoui in 2011 and is headquartered in Grenoble, France.

eCential Robotics SAS is a French Grenoble-based company that specializes in surgical robotics. The company develops and markets a unique system that unifies 2D/3D robotic imaging and real-time navigation. With 80 patents and seven trademarks, it offers orthopedic and neurosurgeons cutting-edge technology to visualize their operations, particularly minimally invasive surgery. The eCential Robotics platform is a universal system open to all implants. The company designs and produces all its equipment in Grenoble, FR, including hardware and software. The company was founded in 2009 by Stéphane Lavallée and Markus Fleute.